- Home
- RWT vs COGT Comparison
RWT vs COGT Comparison
Compare RWT & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWT
- COGT
- Stock Information
- Founded
- RWT 1994
- COGT 2014
- Country
- RWT United States
- COGT United States
- Employees
- RWT N/A
- COGT 205
- Industry
- RWT Real Estate Investment Trusts
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- RWT Real Estate
- COGT Health Care
- Exchange
- RWT Nasdaq
- COGT Nasdaq
- Market Cap
- RWT 756.1M
- COGT 817.5M
- IPO Year
- RWT 1995
- COGT 2018
- Fundamental
- Price
- RWT $6.12
- COGT $7.58
- Analyst Decision
- RWT Buy
- COGT Buy
- Analyst Count
- RWT 11
- COGT 6
- Target Price
- RWT $7.59
- COGT $15.20
- AVG Volume (30 Days)
- RWT 1.1M
- COGT 2.5M
- Earning Date
- RWT 07-31-2025
- COGT 08-05-2025
- Dividend Yield
- RWT 11.76%
- COGT N/A
- EPS Growth
- RWT 105.35
- COGT N/A
- EPS
- RWT 0.21
- COGT N/A
- Revenue
- RWT $241,796,000.00
- COGT N/A
- Revenue This Year
- RWT N/A
- COGT N/A
- Revenue Next Year
- RWT $3.43
- COGT N/A
- P/E Ratio
- RWT $29.02
- COGT N/A
- Revenue Growth
- RWT 29.65
- COGT N/A
- 52 Week Low
- RWT $4.68
- COGT $3.72
- 52 Week High
- RWT $8.15
- COGT $12.61
- Technical
- Relative Strength Index (RSI)
- RWT 67.17
- COGT 66.59
- Support Level
- RWT $5.40
- COGT $7.07
- Resistance Level
- RWT $5.72
- COGT $7.50
- Average True Range (ATR)
- RWT 0.15
- COGT 0.44
- MACD
- RWT 0.06
- COGT -0.04
- Stochastic Oscillator
- RWT 92.31
- COGT 73.99
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.